MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1841 to 1860 of 166,322 approvalsPage 93 of 8317

Recaticimab for Injection

Approval Number: 国药准字S20250002
Registration: Jan 8, 2025

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20253110
Registration: Jan 8, 2025

Brimonidine Tartrate Eye Drops

Approval Number: 国药准字H20253121
Registration: Jan 8, 2025

Loratadine Syrup

Approval Number: 国药准字H20253112
Registration: Jan 8, 2025

Avatrombopag Maleate tablet

Approval Number: 国药准字H20253117
Registration: Jan 8, 2025

Topiramate Tablets

Approval Number: 国药准字H20253069
Registration: Jan 8, 2025

Pregabalin Oral Solution

Approval Number: 国药准字H20253070
Registration: Jan 8, 2025

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253109
Registration: Jan 8, 2025

Omeprazole and Sodium Bicarbonate for Suspension(Ⅰ)

Approval Number: 国药准字H20253084
Registration: Jan 8, 2025

Mecobalamin Injection

Approval Number: 国药准字H20253118
Registration: Jan 8, 2025

Rivaroxaban Granules

Approval Number: 国药准字H20258003
Registration: Jan 8, 2025

Baloxavir Marboxil Tablets

Approval Number: 国药准字H20253114
Registration: Jan 8, 2025

Oseltamivir Phosphate Capsules

Approval Number: 国药准字H20253124
Registration: Jan 8, 2025

Compound Glycyrrhizin Tablets

Approval Number: 国药准字H20253068
Registration: Jan 8, 2025

Terbutaline Sulfate Nebuliser Solution

Approval Number: 国药准字H20253090
Registration: Jan 8, 2025

Midazolam Maleate Tablets

Approval Number: 国药准字H20253111
Registration: Jan 8, 2025

Dabigatran Etexilate Capsules

Approval Number: 国药准字H20253080
Registration: Jan 8, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253075
Registration: Jan 8, 2025

Lenvatinib Mesilate Capsules

Approval Number: 国药准字H20253101
Registration: Jan 8, 2025

Sitagliptin Phosphate/metformin Hydrochloride Tablets

Approval Number: 国药准字H20253074
Registration: Jan 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.